Logo image of HTGM

HTG MOLECULAR DIAGNOSTICS (HTGM) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:HTGM - US40434H3021 - Common Stock

0.48 USD
-0.12 (-20%)
Last: 6/14/2023, 8:00:02 PM
0.4815 USD
+0 (+0.31%)
After Hours: 6/14/2023, 8:00:02 PM
Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to HTGM. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 6.12. This target is 1175% above the current price.
  • HTGM was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about HTGM.
  • In the previous month the buy percentage consensus was at a similar level.
  • HTGM was analyzed by 7 analysts. More opinions would make the average more meaningful.
HTGM Historical Analyst RatingsHTGM Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -78 -71 -64 -57 -50 -43 -36 -29 -22 -15 -8 -1 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 0.486.066.126.126.30 - 1,162.50% 1,175.00% 1,175.00% 1,212.50%
HTGM Current Analyst RatingHTGM Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2023-04-19 HC Wainwright & Co. Reiterate Buy
2023-04-03 HC Wainwright & Co. Maintains Buy
2022-08-15 HC Wainwright & Co. Maintains Buy
2022-05-16 HC Wainwright & Co. Maintains Buy
2022-01-07 Craig-Hallum Upgrade Hold -> Buy
2021-05-14 SVB Leerink Maintains Outperform
2021-05-14 HC Wainwright & Co. Maintains Buy
2021-03-26 HC Wainwright & Co. Maintains Buy

HTG MOLECULAR DIAGNOSTICS / HTGM FAQ

What is the price target for HTGM stock?

7 analysts have analysed HTGM and the average price target is 6.12 USD. This implies a price increase of 1175% is expected in the next year compared to the current price of 0.48.


What is the consensus rating for HTGM stock?

The consensus rating for HTG MOLECULAR DIAGNOSTICS (HTGM) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.